IO Biotech Inc Earnings

The next earnings date for IO Biotech Inc is March 4, 2026.

They are scheduled to announce earnings after the market closes that day.

Analyst Estimates of IO Biotech Inc Earnings

Report DateEstimated Earnings Per Share
03/04/2026$-0.21

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

IO Biotech Inc Earnings: Historical

Report DateBefore/After MarketEarnings Per ShareSurprise %
11/07/2025---$0100.00%
11/05/2025---$0100.00%
08/14/2025---$-0.40-8.11%
08/08/2025---$0100.00%
11/12/2024---$-0.342.80%
08/13/2024---$-0.2814.39%
05/14/2024Before Market$-0.3016.67%
03/05/2024After Market$-0.40-2.56%
11/13/2023Before Market$-0.432.27%
08/11/2023Before Market$-0.74-12.12%
05/11/2023After Market$-0.5915.71%
03/14/2023After Market$-0.70-18.64%
11/09/2022After Market$-0.5616.42%
08/11/2022After Market$-0.645.88%
05/16/2022After Market$-0.609.09%
03/31/2022After Market$-11.96%
12/17/2021After Market$-36.88-2,205.00%
06/30/2021---$-494.09---
03/31/2021---$-494.09---
06/30/2020---$-70.21---
03/31/2020---$-70.21---

More About IO Biotech Inc

Country
USA
Full Time Employees
80

IO Biotech, Inc., a clinical-stage biopharmaceutical company, develops immune-modulating therapeutic cancer vaccines based on the T-win technology platform. The company's lead therapeutic cancer vaccine candidate includes IO102-IO103, which targets cancer cells and immune-suppressive cells in the tumor microenvironment that express indoleamine 2,3-dehydrogenase (IDO), and programmed death-ligand (PD-L1) that is in phase 3 clinical trial to treat melanoma, as well as in phase 2 clinical trial to treat lung, head and neck, and melanoma cancer. It also develops IO112, a product candidate that contains a single Arginase 1-derived peptide to target T cells that recognize epitopes derived from Arginase 1, which is an immunoregulatory enzyme highly expressed in difficult-to-treat tumors associated with high levels of myeloid-derived suppressor cells, including renal cell carcinoma, head and neck, breast, pancreatic, ovarian, colorectal, and prostate cancers. In addition, the company develops IO170, a TGFß1 vaccine for the treatment of solid tumors. IO Biotech, Inc. was incorporated in 2014 and is based in Copenhagen, Denmark.

IO Biotech Inc Earnings” Can Refer to the IO Biotech Inc Earnings Date

Some people say “IO Biotech Inc earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my IO Biotech Inc position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning IO Biotech Inc Stock on the Earnings Date

If you own IO Biotech Inc stock (IOBT) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for IO Biotech Inc might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading IO Biotech Inc shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More IO Biotech Inc Earnings

You can contact us any time if you would like to ask questions about IO Biotech Inc earnings or anything else related to the stock market.